APA (7th ed.) Citation

A, A., Z, A., & D, D. (2026). Comparing COVID-19 vaccine effectiveness in Türkiye: Heterologous, inactivated, and mRNA vaccines. Journal of infection in developing countries, 20(5), 637. https://doi.org/10.3855/jidc.21743

Chicago Style (17th ed.) Citation

A, Ari, Altinay Z, and Demircan D. "Comparing COVID-19 Vaccine Effectiveness in Türkiye: Heterologous, Inactivated, and MRNA Vaccines." Journal of Infection in Developing Countries 20, no. 5 (2026): 637. https://doi.org/10.3855/jidc.21743.

MLA (9th ed.) Citation

A, Ari, et al. "Comparing COVID-19 Vaccine Effectiveness in Türkiye: Heterologous, Inactivated, and MRNA Vaccines." Journal of Infection in Developing Countries, vol. 20, no. 5, 2026, p. 637, https://doi.org/10.3855/jidc.21743.